Stocks · Korea
042520
KOSDAQ
Hans Biomed
An overview for this page is not available in English yet. The figures below are updated daily.
Key figures 2026-10-07 basis
Returns and 52-week range
1W+7.62%
1M+16.92%
3M-1.95%
6M-39.81%
1Y+41.43%
YTD-14.72%
52W high57,800원
52W low12,710원
From 52W high-60.90%
Financial results (consolidated)
| Period | Revenue | Operating income | Net income | OP margin |
|---|---|---|---|---|
| 2022 | 745억 | 13억 | 49억 | 1.7% |
| 2023 | 780억 | -42억 | -241억 | -5.3% |
| 2024 | 811억 | 6억 | -78억 | 0.8% |
| 2025 | 898억 | -259억 | -321억 | -28.8% |
| Quarterly | ||||
| 2024 3Q | 208억 | 7억 | -31,922,207원 | 3.1% |
| 2024 4Q | 200억 | 5억 | -53억 | 2.7% |
| 2025 1Q | 303억 | 21억 | 19억 | 6.8% |
| 2025 2Q | 242억 | 18억 | 7억 | 7.3% |
| 2025 3Q | 220억 | 40,796,559원 | -34억 | 0.2% |
| 2025 4Q | 133억 | -298억 | -312억 | -223.4% |
Company
Address: 서울특별시 송파구 정의로8길 7 9F,11F,12F
Peers in the same sector
Recent filings
- 2026-08-13분기보고서 (2026.06)
- 2026-05-14반기보고서 (2026.03)
Source: DART (Financial Supervisory Service electronic disclosure)
Sources and notes
This page summarizes public filings, market data and news for information only. It is not a recommendation to buy or sell any security. Figures are as of the dates shown; check the original filings before making decisions.